Approval · Notice of Compliance 9252 · 2007
CIPRALEX: Notice of Compliance 9252
Issued December 19, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9252
- Date
- December 19, 2007
- Company
- Lundbeck Canada IncSt-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revisions to the adverse reactions section of the product monograph
- Therapeutic class
- Antidepressant/anxiolytic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CIPRALEX | Not yet assigned | — |
Medicinal ingredients
- ESCITALOPRAM OXALATE 5 MG per TAB
- ESCITALOPRAM OXALATE 10 MG per TAB
- ESCITALOPRAM OXALATE 15 MG per TAB
- ESCITALOPRAM OXALATE 20 MG per TAB